7V91 Stock Overview
Provides healthcare technology and services in France and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Klea Holding SA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €0.16 |
52 Week High | €0.40 |
52 Week Low | €0.16 |
Beta | -0.68 |
11 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | -28.96% |
5 Year Change | n/a |
Change since IPO | -90.93% |
Recent News & Updates
Recent updates
Shareholder Returns
7V91 | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | 0% | -2.8% | -1.0% |
1Y | n/a | -6.2% | -0.5% |
Return vs Industry: Insufficient data to determine how 7V91 performed against the German Medical Equipment industry.
Return vs Market: Insufficient data to determine how 7V91 performed against the German Market.
Price Volatility
7V91 volatility | |
---|---|
7V91 Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 4.2% |
Market Average Movement | 4.6% |
10% most volatile stocks in DE Market | 10.3% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 7V91 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 7V91's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2007 | 94 | Clement Pacaud | www.kleaholding.com |
Klea Holding SA, together with its subsidiaries, provides healthcare technology and services in France and internationally. It offers BewellConnect, an eco-system of health solutions, including enriched and assisted teleconsultation, remote home monitoring, hospital monitoring, tele-expertise, tele-assistance, and tele-regulations; and Smart Salem, a medical fitness screening device. The company was formerly known as Visiomed Group SA and and changed its name to Klea Holding SA in June 2024.
Klea Holding SA Fundamentals Summary
7V91 fundamental statistics | |
---|---|
Market cap | €55.32m |
Earnings (TTM) | €902.00k |
Revenue (TTM) | €13.71m |
61.3x
P/E Ratio4.0x
P/S RatioIs 7V91 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
7V91 income statement (TTM) | |
---|---|
Revenue | €13.71m |
Cost of Revenue | €7.41m |
Gross Profit | €6.30m |
Other Expenses | €5.40m |
Earnings | €902.00k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.0029 |
Gross Margin | 45.95% |
Net Profit Margin | 6.58% |
Debt/Equity Ratio | 32.0% |
How did 7V91 perform over the long term?
See historical performance and comparison